The contribution of bovine complement and antibodies (Ab) against the group B polysaccharidic antigen (GBA) to the opsonization of Streptococcus agalactiae isolated from bovine mastitis cases was investigated by using affinity-purified Ab. GBA-specific Ab were not opsonic by themselves, but in the presence of complement (precolostral calf serum) with an opsonization time of 15 min, they exhibited a dose-dependent opsonic activity in a polymorphonuclear leukocyte chemiluminescence assay. Kinetic studies of the deposition of complement component C3 on protein X-bearing nontypeable (NT/X) strains with an enzyme-linked immunosorbent assay showed that C3 was deposited on bacteria in the absence of Ab but that GBA-specific Ab markedly accelerated the process by reducing the lag phase, which extended up to 15 min when Ab were absent. In the absence of Ab, C3 deposition was inhibited by 5 mM salicylaldoxime or heat treatment at 56°C for 3 min and necessitated Mg2+ ions but not Ca21 ions, suggesting that activation of complement was effected by the alternative pathway only. When GBA-specific Ab were added to complement, the inhibitory treatments lost much of their efficacy, suggesting that the classical pathway was recruited. Deposition of C3 on NT/X strains in the absence of Ab induced chemiluminescence and phagocytic killing. With the addition of GBA-specific Ab, the numbers of surviving bacteria were halved (P < 0.05) compared with killing in the presence of complement alone. It can be concluded that NT/X strains are activators of the alternative pathway of complement and that GBA-specific Ab reinforce the opsonic efficiency of serum by recruiting the classical pathway and slightly enhancing phagocytic killing.
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Streptococcus agalactiae is still a major agent of infection of the bovine mammary gland (30, 45) and produces great losses to dairy workers (9) . S. agalactiae is also a major cause of serious infections in human neonates and also of puerperal infections (1) . Phagocytosis by polymorphonuclear cells (PMN) is considered the major effector of defense in both human and bovine infections by S. agalactiae (2, 41) . Numerous investigations of phagocytosis of S. agalactiae of human origin have led to the conclusion that capsular polysaccharides, which constitute the basis of the serological typing (20) , are the main target of opsonic, protective antibodies (23) . By contrast, few studies have dealt with the phagocytosis of S. agalactiae of bovine origin (17, 25, 26, 37) , and still fewer have addressed the specificity of the antibodies which are opsonic (38) . Fortunately, the knowledge accumulated in the last 15 years in the medical research field can constitute a valuable working basis for investigations of the opsonization of mastitis-causing S. agalactiae. Indeed, bovine and human strains share the same serotypes, which means that, besides the group B polysaccharide antigen (GBA) that is common to all S. agalactiae strains, they bear the same capsular polysaccharides. Nevertheless, a sizeable proportion of S. agalactiae organisms isolated from mastitis cases are nontypeable (28, 44) . Also, the bovine typeable isolates yield smaller amounts of polysaccharidic capsular antigen than do strains of human origin (42) . These observations suggest that a thick capsule is not a requisite of S. agalactiae pathogenicity for the bovine mammary gland. They also suggest that GBA could be more accessible at the surface of strains of bovine origin than on * Corresponding author.
strains of human origin. This could enable GBA-specific antibodies (Ab) to exert some opsonic activity against mastitis-causing S. agalactiae. The present study aimed at testing this possibility by using affinity-purified Ab against GBA and nontypeable as well as encapsulated strains isolated from mastitis cases. The part played by complement in the opsonic process has been showed to be eminent for strains of human origin (3, 4, 12, 13, 19) . Since very little information regarding the contribution of complement in the opsonization of mastitis-causing strains is available, particular attention was devoted to this topic in the present study.
MATERIALS AND METHODS
Bacterial strains. Three strains of S. agalactiae were initially isolated from cases of bovine mastitis. Strains 24 GBA-specific Ab. GBA was purified as described (8) from washed cell walls of a type III strain of human origin (411.19), with some modifications (36) . The preparation was virtually devoid of proteins and reacted with rabbit antiserum against GBA but not against type III polysaccharide (36). GBA was immobilized on a matrix to absorb IS and prepare GBA-specific Ab by affinity chromatography. To prepare the affinity column, GBA (26 mg) in 4 ml of distilled water alkalinized with 30 ,ul of 2 N NaOH was activated by crystals of cyanuric chloride (10 mg) while the pH was monitored with a phenolphthalein indicator. When the solution became colorless (pH 8.0 to 8.2), 3.3 ml of the mixture was pipetted into a tube containing 8 ml of swollen aminohexyl-Sepharose gel (Pharmacia Fine Chemicals, Uppsala, Sweden) in 0.1 M phosphate-buffered saline (PBS), pH 8.0, avoiding transfer of cyanuric chloride crystals. The tube was agitated gently end over end at 8°C overnight. The gel was then washed with 0.1 M NaCl in PBS on a glass-sintered filter. The washings were collected, and their carbohydrate content was evaluated by the phenol-sulfuric acid method (10) . Slightly more than 5 mg of GBA was coupled to the gel.
Heat-treated (56°C, 30 min) IS (24 ml) was absorbed by being passed over the affinity column. The unretained fraction was collected in 1-ml volumes and considered to be absorbed IS. Then, the column was washed with 20 bed volumes of PBS followed by 2.5 volumes of 1 M NaCl. The retained material was eluted with 0.2 M glycine-HCl buffer, pH 2.8. K2HPO4 (1 M) was used to quickly bring the pH back to 7.5. The fractions absorbing at 280 nm were pooled. Assuming an extinction coefficient of 1.37 for bovine immunoglobulins (Ig) (11), a total of 16 mg of Ab was recovered from the 24 ml of IS. These GBA-specific Ab were divided into portions and stored at -18°C either at a concentration of 2 mg/ml in PBS or half diluted in glycerol.
Serum treatments. Inactivation of both complement pathways was accomplished by heating serum at 56°C for 30 mn or by chelating both Ca2" and Mg2' ions with 10 mM EDTA (Sigma). The classical complement pathway was inactivated by treating serum with 5 mM MgCl2 and 10 mM ethylene glycol-tetraacetic acid (EGTA) (Sigma) (14) . PCS was incubated with bivalent ion chelators for 10 min at room temperature before use. Salicylaldoxime (Sigma) from a stock solution of 0.1 M in 0.15 M NaCl was used at final concentrations of 5 mM and 10 mM; at low concentrations it preferentially inhibits the alternative pathway (31, 32) . PCS was depleted of factor B activity by heating at 56°C for 3 min, which inhibits the alternative pathway but leaves an active classical pathway of complement activation (33) . PCS (1.5 ml) was desalted by passage at 4°C through a Sephadex G-25 (Pharmacia) column that had been equilibrated with PBS devoid of Ca2' and Mg2e ions. This desalted PCS was stored at -70°C in small portions until use.
Evaluation of Ab by ELISA. The deposition of Ab on bacteria was monitored by an enzyme-linked immunosorbent assay (ELISA) with whole bacteria (strain 443.31) as antigen, as described previously (38) , with some modifications. Gelatin (0.5%) was used instead of skim milk to reduce nonspecific adsorption of protein. The main difference was that monoclonal Ab specific for bovine IgGl, IgG2, and IgM were used to render the ELISA isotype specific (43) . The sequence of incubation steps was as follows: (i) appropriate dilution of bovine serum or GBA-specific Ab, (ii) mouse monoclonal Ab specific for bovine Ig isotype, (iii) biotinylated sheep Ab anti-mouse Ig, (iv) streptavidin-horseradish peroxidase (Amersham International plc, Amersham, United Kingdom), (v) substrate of peroxidase. Appropriate dilutions of immune reagents were dispensed in 100-,ul samples to triplicate wells. Following each incubation step at 37°C, the plates were washed three times with PBS supplemented with 0.1% Tween 20.
The assay for GBA-specific IgGl, IgG2, and IgM was carried out by the same ELISA procedure except that the antigen was purified GBA coupled to poly-L-lysine (molecular weight, 52,000; Sigma) with cyanuric chloride (Aldrich) as described (16) to make it adherent to the plastic surface of microtiter plates (Immunoplate; Nunc, Roskilde, Denmark).
Assessment of deposition of C3 by ELISA. Microtiter plates were coated with untreated bacteria (strain 443.31) as for the ELISA used to detect Ab against whole bacteria. The sequence of incubation steps, separated by three washings in PBS-Tween 20, was as follows: (i) appropriate dilution in Dulbecco's PBS supplemented with 0.1% gelatin (DPBS-G) of PCS with or without GBA-specific Ab (10 ,ug/ml), (ii) mouse monoclonal Ab (MD3) specific for the a-chain of bovine C3 (5), (iii) peroxidase-conjugated goat Ab to mouse IgG (Jackson Immunoresearch Laboratory, West Grove, Pa.), (iv) peroxidase substrate. Appropriate dilutions of immune reagents in PBS-Tween 20 were dispensed in 100-,ul samples to triplicate wells and incubated for 30 min at 37°C. Wells that received PBS instead of PCS served as blanks.
CL assay (38) . Bovine PMN were isolated from the blood of a donor cow (6) and suspended in DPBS-G (2 x 106 cells per ml). Purity and viability (exclusion of trypan blue) both exceeded 95%. The PMN suspension (200 IlI) and 100 pl of a 10-4 M solution of Luminol (Sigma) were added to 200 pl of opsonized bacteria. The bacterium-to-PMN ratio was about 40. Chemiluminescence (CL) was measured at 38.5°C in a photometer (Luminometer 1251; LKB-Wallac, Turku, Finland) connected to a microcomputer. In each run, test cuvettes containing PMN with either unopsonized bacteria or 5% PCS without bacteria were used. Assays were carried out in duplicate. Most duplicate values differed by less than 5%. CL was expressed in millivolts.
Assay of phagocytic killing. Bacteria were cultivated at 37°C in Todd-Hewitt broth for 18 h. A 1-ml portion of overnight culture was inoculated into 10 ml of fresh ToddHewitt broth and incubated at 37°C for 3 h to obtain bacteria in the log phase of growth. Then, bacteria were washed once in PBS and standard suspensions were prepared by diluting the washed organisms in DPBS-G to an optical density (OD) of 0.3 at 600 nm, which corresponds to approximately 2 x 108 CFU/ml. Bacteria were opsonized for 60 min at 37°C by mixing 200 pl of a 10-fold dilution of the standard suspension of bacteria (2 x 107 CFU, 50 ,ul of PCS, 10 p,l of GBAspecific Ab (1 mg/ml), 240 pl of DPBS-G in polypropylene tubes (12 by 75 mm). Then, 200 pl of the PMN suspension (107/ml) was added and the reaction mixture was made up to a total volume of 1 ml with DPBS-G. The tubes were incubated for 2 h at 37°C with end-over-end rotation. Immediately before and at the end of incubation, 100-pA samples were made in sterile saline. CFU counts were estimated by streaking 100-pl samples on the surface of predried sheep blood agar plates. Results were expressed as the logarithm of the reduction in CFU numbers and were means from four To test the possibility that improved CL resulted from the presence of Ab against GBA, the IS was absorbed by being passed over a column of immobilized GBA. The retained Ab were eluted, and their opsonizing activity was evaluated. The CL response was markedly reduced after absorption, and the activity was restored by the addition of affinitypurified Ab to absorbed IS (Fig. 1) (Fig. 2) . Interestingly, the purified Ab against GBA were active in the CL assay in the presence of complement (Fig. 2) , showing that this capsular antigenbearing strain of bovine origin was opsonized by Ab directed to GBA. Also, PCS alone demonstrated a nonnegligible activity in the CL assay (Fig. 2) .
The contribution of complement and the effect of increasing concentrations of affinity-purified Ab against GBA were assessed by using two nontypeable strains of bovine origin, the prototype NT/X strain 24/60 and strain 443.31. In the absence of opsonins, strain 24/60 elicited a modest CL response which was not augmented by Ab against GBA, whatever the dose tested (Fig. 3) . Strain 443.31 did not induce CL in the absence of opsonins, and the addition of Ab against GBA remained without effect (Fig. 3) . In the presence of 5% PCS, there was a dose-response curve of CL with the two strains, which peaked at a concentration of 5 ,ug of Ab per ml and ended by a plateau (Fig. 3) . At the concentration of 5% and with an incubation time of 15 min, PCS induced only a slight increase in CL over the CL provoked by unopsonized bacteria but enabled GBA-specific Ab to express a CL-promoting activity. As the role of complement appeared to be crucial in the opsonization of NT/X strains of S. agalactiae, investigations of the deposition on bacteria of the potentially opsonic C3 component were undertaken.
Deposition of opsonins on NT/X strains of bovine origin. sources of Ab used in this study, by using purified GBA coupled to pOly-L-lysine as the antigen in the ELISA (Table  1) . Before immunization, bovine serum contained Ab against GBA, but immunization markedly reinforced the Ab activity. Absorbed serum lost most of its activity, this time also in the IgG2 isotype, suggesting that the remaining IgG2 activity detected with the whole-bacterium ELISA was not directed to GBA but to other surface antigens. The fraction of IS retained by and eluted from the affinity column, and referred to as GBA-specific Ab, demonstrated an Ab activity against both purified GBA and whole bacteria in the IgGl and IgG2 isotypes, with a low activity in the IgM isotype. Contribution of the classical and the alternative pathways to deposition of C3. The contribution of the two main pathways of activation of complement was investigated with the ELISA measuring the deposition of C3 on whole bacteria (Table 2) . Various inhibiting treatments were applied to PCS, the source of complement. Treatment of PCS with 10 mM EDTA or heat treatment at 56°C for 30 min abolished the ELISA response. These treatments are known to inactivate the two pathways of complement activation. This result also demonstrated that C3, which is not destroyed by these treatments, did not absorb passively to bacteria and that the ELISA gives negative results in the absence of an active cascade of complement activation. Heat treatment of PCS at 56°C for 3 min, which destroys mainly factor B of the alternative pathway (33) , resulted in almost complete abrogation of the ELISA response in the absence of Ab, whereas in its presence the decrease was moderate. Treatment of PCS with salicylaldoxime, which has been reported to inhibit essentially the alternative pathway when used at low concentrations (31, 32) , abolished the ELISA response of the Ab-independent opsonization. In the presence of Ab there was some inhibition, which was greater with the higher concentration of salicylaldoxime. These results suggest that the alternative pathway was responsible for C3 deposition effected by PCS. Nevertheless, chelation of divalent ions of PCS with Mg-EGTA, which is used as an inhibitor of the Ca-dependent activity of Cl (14), provoked a major reduction in ELISA activity ( Relationship between deposition of C3 and phagocytosis. A limiting concentration of complement, i.e., 5% PCS, was used to show the influence on the CL response of PMN mixed with bacteria (strain 443.31) of both the opsonization incubation time and the addition of Ab against GBA (Fig. 5) . Unopsonized bacteria or bacteria opsonized with Ab alone did not stimulate PMN. Opsonization with PCS for 15 min elicited only a slight CL response, which contrasted with the good CL response obtained when PCS was supplemented with Ab against GBA or when PCS was incubated for 45 min. With incubation for 45 min, the addition of Ab did not augment the CL peak response. Thus, an optimal CL response could be obtained with complement alone, but, under limiting conditions, the presence of GBA-specific Ab reinforced markedly the CL response. Taken together, these results showed a good relationship between the deposition of C3 and the CL response of PMN.
The CL assay was used as an indirect assay of phagocytosis. The bactericidal activity of PMN mixed with bacteria opsonized under limiting concentration and incubation time (15 min) of complement was determined in order to assess whether the CL responses correlated with the opsonophagocytic killing activity of PMN. Figure 6 shows that with strain 443.31, a reduction in bacterial numbers was obtained only when 5% PCS was supplemented with GBA-specific Ab. With strain 24/60, some killing was obtained at 120 min of incubation with PMN when bacteria were opsonized with PCS alone, which can be related to the modest CL response obtained under the same conditions of opsonization (Fig. 3) . Nevertheless, the supplementation of PCS with GBA-specific Ab improved phagocytic killing. These results showed that the cooperative effect of PCS and GBA-specific Ab In the study of Raff et al. (35) demonstrating the opsonic activity of human GBA-specific monoclonal Ab, a source of complement was systematically incorporated in the opsonizing system. Given the general resistance of the surface of human strains to activation of complement, specific Ab are crucial to opsonization (4, 13, 18, 19) . It must be noted that GBA-specific Ab are not generally considered to play a major role in protection against infection. Rabbit Ab to GBA were not protective in a mouse model (24) and were not active in a CL assay of phagocytosis (19) . In another study, they behaved as poor opsonins compared with Ab against capsular polysaccharide, though they allowed some bactericidal killing by PMN (4) . The opsonic activity demonstrated by human monoclonal Ab against GBA (35) prompted in part the present work, considering that bovine typeable S. agalactiae bear smaller amounts of capsular antigen than do isolates of human origin (42) .
This study specified the contribution of GBA-specific Ab to opsonization of bovine isolates. Ab proved unable to opsonize alone. Their inability to even promote adherence of S. agalactiae to PMN was somewhat disconcerting since adherence to phagocytes possessing receptors for IgG2 (27) could be expected from bacteria coated with Ab rich in IgG2. The main effect of Ab was to facilitate activation and binding of C3 to the bacteria by recruiting the classical pathway of complement activation. Deposition of C3 occurred in the presence of salicylaldoxime, a preferential inhibitor of the alternative pathway (31, 32) , or after heat treatment at 56°C for 3 min, which destroys bovine factor B (33) . A striking effect of the addition of GBA-specific Ab to the opsonic system was the modification of the kinetics of C3 deposition. With complement alone, the protracted lag phase preceding the onset of C3 deposition was an important feature of the process. The duration of the initial lag phase is a characteristic of the alternative pathway (34) (32) , suggesting that some properties of the complement-activating surface are also playing a part.
The importance of Ab cannot be dismissed on the basis of the Ab-independent deposition of C3 on a bacterial surface. First, killing of C3-coated bacteria could be increased by additional opsonization by Ab directed to outer surface antigens, as it was when GBA-specific Ab were added to complement. Second, the biological fluid in which opsonization and phagocytosis take place in mastitis cases is milk. The point is that bovine milk has a very low complement activity (40) . In fact, complement activity in milk has been revealed through C3bi conglutinogenic activity (7) and by hemolytic and bactericidal assays (29, 39) , not through the deposition of C3 on bacteria. Thus, whether normal milk can enable enough C3 deposition to render bacteria suitable for phagocytosis by PMN remains to be shown before the role of Ab can be fully evaluated. Also, Ab may be able to act in the absence of complement. Recently, we have shown that heat-treated serum of cows immunized with protein X of S. agalactiae was still more opsonizing than untreated preimmune serum (38) . This could indicate that GBA is not the best target of opsonins on mastitis-causing S. agalactiae, as far as phagocytosis is to take place in a medium in which complement activity is reduced, as it is in milk from an uninflamed mammary gland. The opsonic activity of antibodies directed to capsular polysaccharides or surface proteins, such as protein X, deserves investigation. GBA-specific Ab present the great advantage of reacting with every strain and are able to reinforce the phagocytic killing, but they are dependent on complement activity. This indicates that GBAspecific Ab are likely to be useful as soon as inflammation develops, with the supply of complement afforded by exudation of plasma (29, 39) .
